Lactobacillus casei and bifidobacterium lactis supplementation reduces tissue damage of intestinal mucosa and liver after 2,4,6-trinitrobenzenesulfonic acid treatment in mice.
Authors: Bellavia, M; Rappa, F; Lo Bello, M; Brecchia, G; Tomasello, G; Leone, A; Spatola, G; Uzzo, ML; Bonaventura, G; David, S; Damiani, P; Hajj Hussein, I; Zeenny, MN; Jurjus, A; Schembri-Wismayer, P; Cocchi, M; Zummo, G; Farina, F; Gerbino, A; Cappello, F; Traina, G
